Our Take
A national health system betting 10 million patients on an unproven delivery model is news; whether it works is a 12-month question, not today's story.
Why it matters
This is the first major government contract for AI-supervised physical therapy at population scale. If Portugal's rollout succeeds—or fails visibly—it will directly inform Medicare's reimbursement calculus for similar models in the U.S.
Do this week
Health systems evaluating virtual physical therapy vendors: request published outcomes from the Portugal deployment once available (expected within 6-9 months) before committing to multi-year contracts.
Portugal's health system backs AI therapy at scale
Portugal's National Health Service this month signed an agreement with Sword Health to make AI-powered physical therapy available to the country's entire population of 10 million people. After a doctor's referral, patients will receive unlimited access to Sword's virtual therapy platform, which uses artificial intelligence to guide and supervise care.
Sword Health, founded a decade ago in Portugal, has grown into one of the most prominent digital health companies offering chronic condition management in the United States. The company's model uses AI to monitor patient movement and provide real-time feedback during exercises, reducing the need for in-person therapist supervision.
The deal represents the largest national deployment of AI-assisted physical therapy to date. No comparable government health system has committed to this model across an entire population.
Medicare is watching this closely
The agreement comes amid intensifying debate in the U.S. about how Medicare should pay for AI-based care. Sword's CEO has positioned the Portugal deal as a potential template for American reimbursement policy, according to STAT's reporting.
A successful deployment in Portugal would provide the first real-world evidence that AI-supervised physical therapy can work at scale within a public health system. That evidence matters because U.S. policymakers currently lack comparable data. Medicare's coverage decisions for digital health rely heavily on demonstrated clinical outcomes and cost-effectiveness. Portugal's experience will either validate the model or expose operational and clinical friction that vendors have not yet disclosed.
Conversely, if adoption is slow, compliance poor, or clinical outcomes below expectations, it signals that the technology is not yet ready for the scale Sword is marketing.
What to watch
Health systems considering virtual physical therapy platforms should treat Portugal as a live pilot, not a proof of concept. The difference: pilots have public accountability and reporting requirements; proof of concepts do not.
Request from any vendor claiming national-scale deployment readiness: published quarterly uptake data (referral rates, patient activation, session completion), adverse event reporting, and clinical outcome comparisons (pain reduction, return-to-work timelines, rehospitalization rates) from the Portuguese deployment. If Sword or any competitor cannot provide these within 6 to 9 months, their claims about readiness remain vendor-only assertions.